These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


456 related items for PubMed ID: 9217656

  • 21. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts.
    Hippeläinen M, Syrjänen S, Hippeläinen M, Koskela H, Pulkkinen J, Saarikoski S, Syrjänen K.
    Sex Transm Dis; 1993; 20(6):321-8. PubMed ID: 8108754
    [Abstract] [Full Text] [Related]

  • 22. Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa.
    Chikandiwa A, Pisa PT, Muller EE, Tamalet C, Mayaud P, Chersich MF, Delany-Moretlwe S.
    Sex Transm Dis; 2019 May; 46(5):347-353. PubMed ID: 30985636
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Human papillomavirus genotype distribution in genital warts among women in Harare-Zimbabwe.
    Manyere NR, Dube Mandishora RS, Magwali T, Mtisi F, Mataruka K, Mtede B, Palefsky JM, Chirenje ZM.
    J Obstet Gynaecol; 2020 Aug; 40(6):830-836. PubMed ID: 31790323
    [Abstract] [Full Text] [Related]

  • 25. Simultaneous detection by consensus multiplex PCR of high- and low-risk and other types of human papilloma virus in clinical samples.
    Zheng PS, Li SR, Iwasaka T, Song J, Cui MH, Sugimori H.
    Gynecol Oncol; 1995 Aug; 58(2):179-83. PubMed ID: 7622102
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The interaction of high and low-risk human papillomavirus genotypes increases the risk of developing genital warts: A population-based cohort study.
    Hasanzadeh M, Rejali M, Mehramiz M, Akbari M, Mousavi Seresht L, Yazdandoost Y, Farokhi S, Mahdian Z, Maleki F, Emamdadi-Aliabad Z, Jalilvand N, Khorrami S, Fadaei Z, Movahedi M, Hosseini Z, Razmi F, Takamoli T, Ferns GA, Avan A.
    J Cell Biochem; 2019 Aug; 120(8):12870-12874. PubMed ID: 30868650
    [Abstract] [Full Text] [Related]

  • 28. Preventing cervical cancer and genital warts - How much protection is enough for HPV vaccines?
    Stanley M.
    J Infect; 2016 Jul 05; 72 Suppl():S23-8. PubMed ID: 27211079
    [Abstract] [Full Text] [Related]

  • 29. Epidemiology and natural history of genital human papillomavirus infection.
    Weaver BA.
    J Am Osteopath Assoc; 2006 Mar 05; 106(3 Suppl 1):S2-8. PubMed ID: 16729554
    [Abstract] [Full Text] [Related]

  • 30. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis.
    Manhart LE, Koutsky LA.
    Sex Transm Dis; 2002 Nov 05; 29(11):725-35. PubMed ID: 12438912
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical and virological associations between external anogenital warts and cervical HPV infection in an STD clinic population.
    Law CL, Merianos A, Grace J, Rose BR, Thompson CH, Cossart YE.
    Int J STD AIDS; 1991 Nov 05; 2(1):30-6. PubMed ID: 1645205
    [Abstract] [Full Text] [Related]

  • 33. Human papillomavirus and invasive cervical cancer in Brazil.
    Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJ, Walboomers JM.
    Br J Cancer; 1994 Jan 05; 69(1):114-9. PubMed ID: 8286192
    [Abstract] [Full Text] [Related]

  • 34. Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance.
    Baken LA, Koutsky LA, Kuypers J, Kosorok MR, Lee SK, Kiviat NB, Holmes KK.
    J Infect Dis; 1995 Feb 05; 171(2):429-32. PubMed ID: 7844382
    [Abstract] [Full Text] [Related]

  • 35. [Human papillomavirus and cervical neoplasia].
    Rosa MI, Medeiros LR, Rosa DD, Bozzeti MC, Silva FR, Silva BR.
    Cad Saude Publica; 2009 May 05; 25(5):953-64. PubMed ID: 19488480
    [Abstract] [Full Text] [Related]

  • 36. Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States).
    Hisada M, van den Berg BJ, Strickler HD, Christianson RE, Wright WE, Waters DJ, Rabkin CS.
    Cancer Causes Control; 2001 May 05; 12(4):335-41. PubMed ID: 11456229
    [Abstract] [Full Text] [Related]

  • 37. Concordance of HPV-DNA in cervical dysplasia or genital warts in women and their monogamous long-term male partners.
    Rob F, Tachezy R, Pichlík T, Škapa P, Rob L, Hamšíková E, Šmahelová J, Hercogová J.
    J Med Virol; 2017 Sep 05; 89(9):1662-1670. PubMed ID: 28390162
    [Abstract] [Full Text] [Related]

  • 38. Risk factors associated with cervical human papillomavirus infections: a case-control study.
    Kataja V, Syrjänen S, Yliskoski M, Hippelïnen M, Väyrynen M, Saarikoski S, Mäntyjärvi R, Jokela V, Salonen JT, Syrjänen K.
    Am J Epidemiol; 1993 Nov 01; 138(9):735-45. PubMed ID: 8237988
    [Abstract] [Full Text] [Related]

  • 39. Clinical presentation and natural course of anogenital warts.
    Handsfield HH.
    Am J Med; 1997 May 05; 102(5A):16-20. PubMed ID: 9217658
    [Abstract] [Full Text] [Related]

  • 40. Human papillomavirus prevalence in pregnancy.
    Kemp EA, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J.
    Obstet Gynecol; 1992 May 05; 79(5 ( Pt 1)):649-56. PubMed ID: 1314358
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.